Perfil
Paul Dick is currently a Partner at Vet Venture Capital, Inc. He was previously the Chief Executive Officer & Director at Avivagen, Inc. from 2008 to 2010.
He also served as a Director at AbCelex Technologies, Inc. Dr. Dick holds a doctorate degree from the University of Guelph.
Cargos activos de Paul Dick
| Empresas | Cargo | Inicio |
|---|---|---|
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Paul Dick.
| Empresas | Cargo | Fin |
|---|---|---|
| AVIVAGEN INC. | Presidente | 01/10/2010 |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Director/Miembro de la Junta | - |
Formación de Paul Dick.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avivagen, Inc.
Avivagen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes health supplements for animals & pets | Commercial Services |
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Finance |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Bolsa de valores
- Insiders
- Paul Dick
















